News Releases »
Find out about the latest news in our business and references to Katan in international publications.
View News Releases: All 2005 2004 2003 2002 2001 2000
11/1/2003 — Biotechnology Investment Today: In Coversation with.......Stan YakatanThe Winter 2003 issue of Biotechnology Investment Today featured this article on Stan. In it he discusses the role of M&A igloban the overall development of the biotechnology sector. Learn More » |
9/29/2003 — LifePoint Announces Appointment of Chairman of the BoardLifePoint, Inc. (AMEX:LFP), a leader in non-invasive drug diagnostic technologies and solutions, announced today the appointment of director Stan Yakatan as the new non-employee Chairman of the Board of Directors. Learn More » |
6/25/2003 — Dermatrends Engages Katan to Seek PartnershipsDermatrends, Inc., a privately held research and development company devoted to transdermal and other drug delivery technologies has engaged Katan to assist it in developing licensing opportunities for its transdermal technology. Learn More » |
6/1/2003 — Biotechnology Investment Today: In conversation with....Stan YakatanThe Spring 2003 issue of Biotechnology Investment Today featured this article on Stan. In it he discusses global development of biotechnology. Learn More » |
2/10/2003 — Katan and BSI Announce Strategic Partnership for AustraliaKatan International and BSI have decided to join forces to provide a depth of experience to biotech companies. Learn More » |
2/3/2003 — Genetronics Stockholders Approve BTX SaleGenetronics Biomedical Corporation, (GEB) announced today the completion of the sale of substantially all of the properties and assets that are primarily used in its BTX Division. Katan acted as GEB`s principal advisor on this transaction. Learn More » |
